| Literature DB >> 35008061 |
Dirk Debus1, Semra Genç2, Philipp Kurz2, Martin Holzer3, Kurt Bauer3, Ralph Heimke-Brinck4, Martin Baier4, Heidi Sebald5, Andrea Debus5, Christian Bogdan5,6, Kurt-Wilhelm Stahl7.
Abstract
Cutaneous leishmaniasis (CL) frequently entails chronic skin lesions that heal only slowly. Until now, the available therapeutic options are very limited. Here, we present a case of a 5½-year-old Syrian refugee with two progressive lower-leg skin ulcers caused by Leishmania tropica. The patient received topical treatment with LeiProtect®, a newly developed, hydroxypropylcellulose-based, filmogenic gel containing nontoxic concentrations of pharmaceutical sodium chlorite. The skin lesions completely healed within 8 weeks and did not relapse during 1 year of follow-up, underlining the efficacy of this novel local therapy of CL.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35008061 PMCID: PMC8922486 DOI: 10.4269/ajtmh.21-0962
Source DB: PubMed Journal: Am J Trop Med Hyg ISSN: 0002-9637 Impact factor: 3.707